18.207.136.189
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Internal Medicine

Semaglutide leads to substantial, sustained weight loss over 2 years

Overweight (≥1 weight-related comorbidity) or obese adults treated with semaglutide had substantial, sustained weight loss over 104 weeks compared with placebo, according to a study. In the STEP 5 trial, 304 participants (236 of which were female) were randomly assigned to semaglutide 2.4 mg (n = 152) or placebo (n...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-